Apoptosis is a highly coordinated, multistep process that is often deregulated in diseases such as cancer and autoimmune disorders. It is associated with chromosomal fragmentation by deoxyribonucleases (DNases). Although many DNases have been characterized, Nakagawa et al. have discovered that Dicer, a highly conserved ribonuclease (RNase) that is known to produce small gene-silencing RNAs, also functions in chromosomal fragmentation. Researchers demonstrated that Dicer (dcr-1) gene inactivation in C. elegans blocks chromosomal fragmentation. The apoptosis executioner enzyme CED-3 caspase cleaves DCR-1 to generate a DCR-1 fragment with DNase activity that destroys its RNase function. Overexpression of the DCR1 DNase fragment induces DNA fragmentation. This discovery shows the conversion potential of an RNase to a DNase, and elucidates an important regulatory mechanism in apoptosis, which is relevant to many human diseases.
Cancer: the two faces of Dicer
Cancer: the two faces of Dicer. Dis Model Mech 28 April 2010; 3 (5-6): 256. doi:
Download citation file:
Advertisement
Cited by
Special Issue: The RAS Pathway

Our latest special issue is now complete. It showcases RAS-driven mechanisms of disease progression, and highlights approaches to treat and modify the disease course in model systems.
Call for papers: Moving Heart Failure to Heart Success

Disease Models & Mechanisms is pleased to welcome submissions for consideration for an upcoming special issue, Moving Heart Failure to Heart Success: Mechanisms, Regeneration & Therapy. Submission deadline: 4 July 2022.
Propose a new Workshop

Our Workshops bring together leading experts and early-career researchers from a range of scientific backgrounds. Applications are now open to propose Workshops for 2024, one of which will be held in a Global South country. .
A focus on Drosophila

In a series of front section articles, DMM is highlighting the versatility, breadth, and scope of Drosophila research in human disease modelling and translational medicine.
Apply for a DMM Conference Travel Grant

Aimed at early-career researchers wanting to attend in-person and virtual meetings, the next application deadline for a DMM Conference Travel Grant is 6 June 2022. Find out more and hear from past recipients about their experience of the grant.
Other journals from
The Company of Biologists